These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3481337)

  • 1. Naloxone-reversible antidiarrheal effects of enkephalinase inhibitors.
    Marçais-Collado H; Uchida G; Costentin J; Schwartz JC; Lecomte JM
    Eur J Pharmacol; 1987 Dec; 144(2):125-32. PubMed ID: 3481337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetorphan, an enkephalinase inhibitor, decreases gastric secretion in cats.
    Bado A; Chicau-Chovet M; Appia F; Dubrasquet M; Lecomte JM; Rozé C
    Peptides; 1987; 8(1):89-93. PubMed ID: 3554169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
    Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
    J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of enkephalinase inhibitors on gastric emptying in mice depends on the nature of the meal.
    Liberge M; Rivière PM; Buéno L
    Life Sci; 1988; 42(21):2047-53. PubMed ID: 3164437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of naloxone-precipitated opioid withdrawal symptoms by peripheral administration of the enkephalinase inhibitor acetorphan.
    Livingston SJ; Sewell RD; Rooney KF; Smith HJ
    Psychopharmacology (Berl); 1988; 94(4):540-4. PubMed ID: 3131801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
    Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
    J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF.
    Spillantini MG; Geppetti P; Fanciullacci M; Michelacci S; Lecomte JM; Sicuteri F
    Eur J Pharmacol; 1986 Jun; 125(1):147-50. PubMed ID: 3015640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origin of the stimulation of food intake by oral administration of enkephalinase inhibitors in sheep.
    Rivière PJ; Buéno L
    Life Sci; 1987 Jul; 41(3):333-9. PubMed ID: 3298911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous opiate reward induced by an enkephalinase inhibitor, thiorphan, injected into the ventral midbrain.
    Glimcher PW; Giovino AA; Margolin DH; Hoebel BG
    Behav Neurosci; 1984 Apr; 98(2):262-8. PubMed ID: 6586195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of enkephalinase activity attenuates naloxone-precipitated withdrawal symptoms.
    Haffmans J; Dzoljic MR
    Gen Pharmacol; 1987; 18(1):103-5. PubMed ID: 3549428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enkephalinase is involved in the degradation of endogenous substance P released from slices of rat substantia nigra.
    Mauborgne A; Bourgoin S; Benoliel JJ; Hirsch M; Berthier JL; Hamon M; Cesselin F
    J Pharmacol Exp Ther; 1987 Nov; 243(2):674-80. PubMed ID: 2445957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endogenous enkephalins in locomotion evidenced by acetorphan, an "enkephalinase" inhibitor.
    Michael-Titus A; Preterre P; Giros B; Costentin J
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1062-6. PubMed ID: 3121843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of stress-induced analgesia (SIA) by thiorphan and its block by naloxone.
    Chipkin RE; Latranyi MB; Iorio LC
    Life Sci; 1982 Sep 20-27; 31(12-13):1189-92. PubMed ID: 6958954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enkephalinase inhibitors attenuate naloxone-precipitated withdrawal syndrome.
    Dzoljic MR
    NIDA Res Monogr; 1986; 75():575-8. PubMed ID: 3123978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analgesic effects of morphine, but not those of the enkephalinase inhibitor thiorphan, are enhanced in arthritic rats.
    Kayser V; Guilbaud G
    Brain Res; 1983 May; 267(1):131-8. PubMed ID: 6574799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of [D-ala2]enkephalinamide analgesia in rats by thiorphan.
    Chipkin RE; Latranyi MZ; Iorio LC; Barnett A
    Eur J Pharmacol; 1982 Sep; 83(3-4):283-8. PubMed ID: 6756941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of the hypoglycemic effect of insulin by thiorphan, an enkephalinase inhibitor.
    Chipkin RE; Kreutner W; Billard W
    Eur J Pharmacol; 1984 Jun; 102(1):151-4. PubMed ID: 6383841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enkephalinase inhibitor potentiates substance P- and electrically induced contraction in ferret trachea.
    Sekizawa K; Tamaoki J; Nadel JA; Borson DB
    J Appl Physiol (1985); 1987 Oct; 63(4):1401-5. PubMed ID: 2447055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantiomers of [R,S]-thiorphan: dissociation of analgesia from enkephalinase A inhibition.
    Scott WL; Mendelsohn LG; Cohen ML; Evans DA; Frederickson RC
    Life Sci; 1985 Apr; 36(13):1307-13. PubMed ID: 2984500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between enkephalinase inhibition of thiorphan in vivo and its analgesic activity.
    Hachisu M; Takahashi H; Hiranuma T; Shibazaki Y; Murata S
    J Pharmacobiodyn; 1985 Sep; 8(9):701-10. PubMed ID: 3910797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.